O	0	7	SUMMARY	SUMMARY	NN	B-NP

O	8	12	Both	Both	CC	O
O	13	16	the	the	DT	B-NP
O	17	23	innate	innate	JJ	I-NP
O	24	27	and	and	CC	I-NP
O	28	36	adaptive	adaptive	JJ	I-NP
B-Anatomical_system	37	43	immune	immune	JJ	I-NP
I-Anatomical_system	44	54	subsystems	subsystem	NNS	I-NP
O	55	58	are	be	VBP	B-VP
O	59	68	necessary	necessary	JJ	B-ADJP
O	69	71	to	to	TO	B-VP
O	72	79	provide	provide	VB	I-VP
O	80	82	an	an	DT	B-NP
O	83	92	effective	effective	JJ	I-NP
O	93	99	immune	immune	JJ	I-NP
O	100	108	response	response	NN	I-NP
O	109	116	whether	whether	IN	B-SBAR
O	117	119	to	to	TO	B-PP
O	120	122	an	an	DT	B-NP
O	123	129	actual	actual	JJ	I-NP
O	130	140	pathogenic	pathogenic	JJ	I-NP
O	141	146	agent	agent	NN	I-NP
O	147	149	or	or	CC	B-PP
O	150	152	to	to	TO	B-PP
O	153	155	an	an	DT	B-NP
O	156	168	immunization	immunization	NN	I-NP
O	168	169	.	.	.	O

O	170	177	Further	Further	RB	B-ADVP
O	177	178	,	,	,	O
O	179	188	effective	effective	JJ	B-NP
O	189	202	immunizations	immunization	NNS	I-NP
O	203	207	must	must	MD	B-VP
O	208	214	induce	induce	VB	I-VP
O	215	219	long	long	JJ	B-NP
O	219	220	-	-	HYPH	I-NP
O	220	224	term	term	NN	I-NP
O	225	236	stimulation	stimulation	NN	I-NP
O	237	239	of	of	IN	B-PP
O	240	244	both	both	CC	O
O	245	248	the	the	DT	B-NP
O	249	256	humoral	humoral	JJ	I-NP
O	257	260	and	and	CC	I-NP
B-Cell	261	265	cell	cell	NN	I-NP
O	265	266	-	-	HYPH	B-NP
O	266	274	mediated	mediate	VBN	I-NP
O	275	279	arms	arm	NNS	I-NP
O	280	282	of	of	IN	B-PP
O	283	286	the	the	DT	B-NP
O	287	295	adaptive	adaptive	JJ	I-NP
O	296	302	system	system	NN	I-NP
O	303	305	by	by	IN	B-PP
O	306	309	the	the	DT	B-NP
O	310	320	production	production	NN	I-NP
O	321	323	of	of	IN	B-PP
B-Cell	324	332	effector	effector	NN	B-NP
I-Cell	333	338	cells	cell	NNS	I-NP
O	339	342	for	for	IN	B-PP
O	343	346	the	the	DT	B-NP
O	347	354	current	current	JJ	I-NP
O	355	364	infection	infection	NN	I-NP
O	365	368	and	and	CC	I-NP
B-Cell	369	375	memory	memory	NN	I-NP
I-Cell	376	381	cells	cell	NNS	I-NP
O	382	385	for	for	IN	B-PP
O	386	392	future	future	JJ	B-NP
O	393	403	infections	infection	NNS	I-NP
O	404	408	with	with	IN	B-PP
O	409	412	the	the	DT	B-NP
O	413	423	pathogenic	pathogenic	JJ	I-NP
O	424	429	agent	agent	NN	I-NP
O	429	430	.	.	.	O

O	431	433	At	At	IN	B-NP
O	434	439	least	least	JJS	I-NP
O	440	445	seven	seven	CD	I-NP
O	446	455	different	different	JJ	I-NP
O	456	461	types	type	NNS	I-NP
O	462	464	of	of	IN	B-PP
O	465	473	vaccines	vaccine	NNS	B-NP
O	474	477	are	be	VBP	B-VP
O	478	487	currently	currently	RB	B-ADVP
O	488	490	in	in	IN	B-PP
O	491	494	use	use	NN	B-NP
O	495	497	or	or	CC	B-PP
O	498	500	in	in	IN	B-PP
O	501	512	development	development	NN	B-NP
O	513	517	that	that	WDT	B-NP
O	518	525	produce	produce	VBP	B-VP
O	526	530	this	this	DT	B-NP
O	531	540	effective	effective	JJ	I-NP
O	541	549	immunity	immunity	NN	I-NP
O	550	553	and	and	CC	O
O	554	558	have	have	VBP	B-VP
O	559	570	contributed	contribute	VBN	I-VP
O	571	578	greatly	greatly	RB	B-ADVP
O	579	581	to	to	TO	B-PP
O	582	585	the	the	DT	B-NP
O	586	596	prevention	prevention	NN	I-NP
O	597	599	of	of	IN	B-PP
O	600	610	infectious	infectious	JJ	B-NP
O	611	618	disease	disease	NN	I-NP
O	619	625	around	around	IN	B-PP
O	626	629	the	the	DT	B-NP
O	630	635	world	world	NN	I-NP
O	635	636	.	.	.	O

